Lamotrigine
NDC 0228-1638, Lamotrigine, tablet, film coated, extended release, from Actavis Pharma, Inc..
- Product NDC
- 0228-1638
- Status
- Listed
- Labeler
- Actavis Pharma, Inc.
- Dosage form
- TABLET, FILM COATED, EXTENDED RELEASE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA200672
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0228-1638 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- LAMOTRIGINE250 mg/1
Pharmacologic classes
Anti-epileptic Agent [EPC]; Decreased Central Nervous System Disorganized Electrical Activity [PE]; Dihydrofolate Reductase Inhibitors [MoA]; Mood Stabilizer [EPC]; Organic Cation Transporter 2 Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0228-1638-03 | 00228163803 | 30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (0228-1638-03) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/87beaf22-593d-4170-bb58-332c615ef90dNADAC price for package 00228163803
GET /v1/drugs/nadac/00228163803
Use it
Look up 0228-1638 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0228-1638 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0228-1638. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.